Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Merck & Co
(NY:
MRK
)
123.50
-2.39 (-1.90%)
Streaming Delayed Price
Updated: 3:04 PM EDT, Jul 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Merck & Co
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
87
88
Next >
Buy/Sell: Wall Street's Top 10 Stock Calls This Week - Sunday, April 16
April 16, 2023
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street’s best analysts during the week of April 10-14.
Via
Talk Markets
Moderna and Merck Announce mRNA-4157 (V940), an Investigational Individualized Neoantigen Therapy, in Combination with KEYTRUDA(R) (Pembrolizumab), Demonstrated Superior Recurrence-Free Survival in Patients with High-Risk Stage III/IV Melanoma Following
April 16, 2023
Via
ACCESSWIRE
Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy Significantly Improved Overall Survival Compared to Chemotherapy Alone in Patients With Advanced or Unresectable Biliary Tract Cancer
April 16, 2023
From
Merck & Co., Inc.
Via
Business Wire
Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.
April 16, 2023
From
Merck & Co., Inc.
Via
Business Wire
Check Out What Whales Are Doing With MRK
April 12, 2023
Via
Benzinga
Where Merck & Co Stands With Analysts
April 10, 2023
Via
Benzinga
Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.
April 16, 2023
From
Prometheus Biosciences
Via
GlobeNewswire
3 Dividend Stocks to Buy for a Recession-Proof Portfolio
April 15, 2023
Many investors believe we’re at the point of no return, leading us to look at some of the best dividend stocks for a recession.
Via
InvestorPlace
10 Best Performing Blue Chip Stocks
April 14, 2023
While there may be varying interpretations among investors, the term “blue chip” typically denotes companies that are regarded as leaders in their respective fields.
Via
Talk Markets
MRK: Chart Of The Week
April 13, 2023
The 20-day moving average is coming in at about 170 – 172, which is 6 above where the current price level is.
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2023
April 13, 2023
Via
Benzinga
AMZN Stock Alert: 12 Takeaways From the 2023 Amazon Shareholder Letter
April 13, 2023
Amazon (AMZN) stock is a hot topic among traders on Thursday after CEO Andy Jassy released his annual shareholder letter.
Via
InvestorPlace
Why Is Merck (MRK) Stock Up Today?
April 13, 2023
Merck (MRK) stock is on the move Thursday after the pharmaceutical company got an update from the FDA concerning Keytruda.
Via
InvestorPlace
Novo Nordisk Charges Higher and Could be Just Getting Started
April 13, 2023
Novo Nordisk stock continues to move higher after announcing a partnership with Aspect Biosystems; but at 47x earnings this is still an expensive stock
Via
MarketBeat
Apple To Rally Around 18%? Here Are 10 Other Analyst Forecasts For Thursday
April 13, 2023
Credit Suisse boosted the price target for Apple Inc. (NASDAQ: AAPL) from $184 to $188. Credit Suisse analyst Shannon Cross maintained an Outperform rating. Apple shares fell 0.4% to close at $160.10...
Via
Benzinga
Analysts At H.C. Wainwright & Co. Set 12-Month Target Of $15 Per Share For ENLV Thanks To High Profile Collaboration Agreement, Multiple Ongoing Clinical Trials
April 13, 2023
This month, H.C. Wainwright & Co.
Via
Benzinga
FDA Accepts Application for Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy as First-Line Treatment for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
April 13, 2023
From
Merck & Co., Inc.
Via
Business Wire
US Stocks Could Flatline As Rate-Hike Doubts Linger: Analyst Sees Market Strength In April Back-Half
April 13, 2023
Trading in the index futures suggests a cautious opening on Thursday as traders put inflation fears on the back burner and look ahead to the first-quarter earnings season.
Via
Benzinga
These 3 Health Care Stocks Delivering High-Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts
April 12, 2023
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
2 Forever Stocks to Buy No Matter What the Market Is Doing
April 11, 2023
These two top stocks are trading at very reasonable prices right now.
Via
The Motley Fool
Joe Biden Plans On Running For Re-Election In 2024, Apple Clocks Highest Decline In Q1 PC Shipments, Fox News Confidential Defamation Lawsuit Settlement: Today's Top Stories
April 10, 2023
Benzinga Biden's 2024 Ambition: President Announces Intent to Pursue Second Term
Via
Benzinga
Moderna Surges On A Key Win For Its Merck-Partnered Cancer Vaccine In Europe
April 10, 2023
Moderna shares are flirting with their key moving averages on a win in Europe.
Via
Investor's Business Daily
Can You Still Buy the Dow Jones' Best-Performing April Stocks?
April 10, 2023
Each is benefiting from recent good news, but there's also a theme-based tailwind brewing that could last a while.
Via
The Motley Fool
Merck, Eisai Shelve Keytruda Plus Lenvima Combo Trial In Skin Cancer Setting, Disappoints In Certain Type Of Colorectal Cancer
April 10, 2023
Via
Benzinga
Week In Review: Suzhou Duality Out-Licenses Two ADCs To BioNTech In $1.7 Billion Deal
April 08, 2023
Duality Biologics out-licensed global rights (ex-China) for two ADC candidates to BioNTech, Pfizer’s partner, for one of the two original COVID-19 vaccines in a deal worth $170 million upfront and up...
Via
Talk Markets
5 S&P 500 Stocks Showing Strength As Recession Fears Rise
April 07, 2023
Medical stocks are holding up amid economic and market uncertainty.
Via
Investor's Business Daily
5 Recession-Proof Stocks With High Cash, Low Debt, Strong Dividends To Protect Your Portfolio In 2023
April 07, 2023
Markets are increasingly concerned about an impending recession following the latest U.S. economic data, which showed a slowing in the pace of growth in the labor market and service sector activity in...
Via
Benzinga
Merck and Eisai Provide Update on Phase 3 Trials of KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) In Certain Patients With Advanced Melanoma (LEAP-003) and Metastatic Colorectal Cancer (LEAP-017)
April 07, 2023
From
Merck & Co., Inc.
Via
Business Wire
MRNA-4157/V940, an Investigational Personalized MRNA Cancer Vaccine, in Combination With Keytruda(R) (Pembrolizumab), Receives Prime Scheme Designation From the European Medicines Agency for Adjuvant Treatment of Patients With High-Risk Stage III/IV
April 06, 2023
Via
ACCESSWIRE
What To Expect When Merus Presents Petosemtamab Data Update At AACR
April 06, 2023
Via
Benzinga
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
87
88
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.